Pepticom initiates beta-testing for its cyclotide discovery algorithm.
If you have a protein target and want to find a cyclotide that binds it, please contact: amit.michaeli@wordpress-544837-1818586.cloudwaysapps.com.
Pepticom’s CEO attended and presented the company and its technology at the Shenzhen International Bio-Valley event.
Pepticom will attend the PEPTIDES conference in London, on July 6-7.
For more information: maayan.elias@wordpress-544837-1818586.cloudwaysapps.com.
Pepticom’s CTO, Amit Michaeli, will present at the Peptide Therapeutics Forum 2017 (Basel life 2017).
The talk: Artificial intelligence designed TLR4 peptide activators, will take place on September 12
Pepticom congratulates Prof. Amiram Goldblum, Pepticom’s co-Founder and Director
For winning the prestigious 2017 Kaye Innovation Award for dramatic improvements in drug discovery methods.
Pepticom will attend the 3rd INNOVATION China-Israel investment summit in China.
For more information and schedule: andre.miodezky@wordpress-544837-1818586.cloudwaysapps.com.
Pepticom’s CEO, Dr. Immanuel Lerner, will attend the 2017 BIO International Convention, June 19-22 in San Diego, California
For more information: maayan.elias@wordpress-544837-1818586.cloudwaysapps.com.
Pepticom is honored to join the Israeli delegation to SelectUSA 2017
Bringing our unique technology together with American minds to create leading products in the 21st century. Come and meet us: amit.michaeli@wordpress-544837-1818586.cloudwaysapps.com.
Pepticom was selected as one of the 500 most promising tech startups to participate in the Pioneers Festival 2017 at the Hofburg Imperial Palace in Vienna.
Come and meet us on June 1-2. For more information, please contact: maayan.elias@wordpress-544837-1818586.cloudwaysapps.com.
2017 Israeli BioMed
Meet us at the Israeli BioMed 2017 on May 25 at booth 8 in the startup pavilion area. For more info, contact: maayan.elias@wordpress-544837-1818586.cloudwaysapps.com.